Could adding a second diabetes drug early save lives?
NCT ID NCT07566299
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study analyzed health records of over 118,000 adults with obesity, type 2 diabetes, and related heart, kidney, and liver conditions. Researchers compared people who added a second type of diabetes drug (GLP-1 or SGLT2) early to those who did not. The goal was to see if early combination therapy reduces death risk over five years.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- GLP-1 receptor agonist and SGLT2 inhibitor
- What this could lead to
- If successful, this could show that adding a second diabetes drug early improves survival and reduces heart, kidney, and liver problems in people with obesity and type 2 diabetes.
- What could go wrong
- This is an observational study using existing health records, not a controlled trial. Results may be affected by unmeasured factors, and the findings need confirmation in prospective studies.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CARDIOVASCULAR-KIDNEY-METABOLIC SYNDROME are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Chung Shan Medical University Hospital
Taichung, Taichung, 402, Taiwan
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a simple scan and blood test outsmart liver cancer?
- Can a new stomach and gut bypass surgery tackle obesity and diabetes?
- Can a Two-Drug combo tip the scales against obesity?
- Seaweed extract may tackle fatty liver Disease—A trial puts it to the test
- Can Weight-Loss surgery change how medications work?
- Coffee grounds probiotic could reshape gut health and fight inflammation